Contract Manufacturing

Apple has scaled up domestic value addition and component manufacturing as global supply chains realign

Tata Group's manufacturing strategy looks similar to China's Luxshare's, says Princeton researcher

Luxshare, founded by a formidable Grace Wang, a former "factory girl" from Shenzhen, now is only second to Foxconn.

Foxconn aims to make India its third EV hub, eyes 5% global market share by 2025

The Taiwanese company has held talks with Telangana and Tamil Nadu governments to set up an EV plant and a decision is expected soon. Bharat FIH, Foxconn’s India arm, has been making components for EV companies such as Ather Energy and Ola Electric since 2015

Ideas For Profit | Are AC companies a cool investment bet?

Low penetration levels coupled with rising temperatures make a compelling case for long-term investment in the AC sector. Near-term visibility on demand front is limited, but the companies in the sector have sufficient liquidity to withstand the demand disruptions caused by Covid. Overall, valuations in the sector appear quite stretched, they seem to factor in long-term positives.

Back to the future: Nokia prepares for mobile comeback

Now Nokia boss Rajeev Suri is planning a comeback. He must wait until late 2016 before he can consider re-entering the handset business - after a non-compete deal with Microsoft expires - but preparations are underway.

Targus to set up manufacturing base in India in 3 months

To be set up under contract manufacturing, the facility will come up in Dehradun with a capacity of up to 2 lakh units a month.

Sun Pharma redoing Ranbaxy contract mfg unit, to halve size

Sources say this to be a natural fallout of Sun‘s stated intent to bring back all outsourced products to in-house facilities, and in turn leaving that division redundant.

P&G says won't renew contract mfg deal with JHS in Himachal

Procter &Gamble cites financial instability of JHS as the majot reason for not renewing the contract mfg deal with JHS in Himachal Pradesh. The contract was for the manufacturing of Tide which was due to expire by June-end.

Jubilant Life expects 3-4 drug approvals in the US in FY12

Jubilant Life Sciences Ltd (JLSL) today said it plans to file applications for about 30 new drugs in the US and Europe and expects to receive approvals for three to four drugs in the American market this fiscal.

Apr-June qtr: Pharma cos to see healthy sales, sick margins

Pharmaceutical sector has been in the pink of health this year with most stocks outperforming the broader market since the beginning of April. However, there could be some suffering ahead.